Capsule Endoscopy Market Size, Share, Opportunities, And Trends By Component (Capsule Endoscopy, Capsule Endoscopy Data Recorder, Capsule Endoscopy Workstations), By Endoscope Type (Cystoscopies, Neuro-Endoscopes), By Product (Small Bowel Capsule, Esophageal Capsule, Colon Capsule), By Application (Obscure Gastrointestinal Bleeding, Crohn’s Disease, Intestine Disease, Others), By End-User (Hospitals, Clinics, Others) And By Geography - Forecasts From 2025 To 2030

Capsule Endoscopy Market Size:

The capsule endoscopy market is expected to grow from USD 605.969 million in 2025 to USD 821.108 million in 2030, at a CAGR of 6.26%.

Capsule Endoscopy Market Trends:

A capsule endoscopy camera is like a vitamin-sized capsule that is swallowed by people. The procedure of Capsule Endoscopy is done with the use of a tiny wireless camera that takes images of the digestive tract. The capsule contains video chips, a light bulb, a battery, and a radio transmitter. It takes thousands of images as it travels through our digestive tract, and sends them through the transmitter. These images are used by the doctor to see areas that cannot be reached easily with traditional endoscopy procedures.

The main use of the capsule is to diagnose gastrointestinal complications, inflammatory bowel diseases, celiac diseases, polyps screening, oesophagus examination, and abnormal tissue growth, where the traditional endoscopy is ineffective, and helps in immediate and faster recovery. The growth of the capsule endoscopy market is substantiated by supportive government initiatives, increasing demand for faster and more accurate diagnostics, growing incidences of intestinal disorders and gastrointestinal diseases, and the increasing geriatric population. However, the risks and complications of capsule endoscopy and the lack of skilled physicians remain major challenges.

Capsule Endoscopy Market Growth Drivers:

The rising geriatric population base is projected to provide the capsule endoscopy market with a strong platform for growth over the analyzed period. Aging significantly increases the risk of gastrointestinal disorders like inflammatory bowel disease, Crohn’s disease, colorectal cancer, and appendicitis, to name a few. Further, the growing prevalence of cancer in older as well as younger adults in recent times and the increasing adoption of screening tests, including capsule endoscopy for detection, are likely to propel market growth. According to the statistics provided by the American Cancer Society, it is projected that about 1.9 million cancer cases will be reported in the US by the end of 2022. Such an increasing prevalence is thus expected to catalyze the growth of the market.

Further, the growing adoption of minimally invasive surgical interventions has accelerated the utilization of capsule endoscopic systems and wireless capsules, mainly for the detection or diagnosis of gastrointestinal issues such as OGIB (obscure gastrointestinal tract bleeding), Crohn’s disease, cancer, and small intestine tumors. Capsule endoscopy provides efficient and rapid results concerning the screening of such conditions, thereby boosting the adoption of this method and leading to market growth.

Adding to that, strategic alliances among market players, such as mergers, acquisitions, and partnerships, along with growing R&D in the area of capsule-based endoscopic technologies, are some of the factors that are further expected to drive the growth of the market. For instance, in 2020, Medtronic announced a partnership with Amazon for the home delivery of its capsule endoscope, PillCam Genius. Through this partnership, it aimed to increase its penetration on a global scale and enhance patient comfort and satisfaction. 

Capsule Endoscopy Market Segment Analysis:

• Application Insights

Based on application, the OGIB segment is expected to hold dominant shares in the market, due to the numerous advantages provided by capsule endoscopy in the diagnosis and detection of OGIB. Additionally, benefits like real-time visualization, image capturing, and analysis of the entire small intestine, along with reliable and precise results, contribute to the increase in the adoption of capsule endoscopes for OGIB. Further, the shift in trend towards the adoption of capsule-based endoscopy screening for OGIB as compared to the other conventional methods, such as double-balloon enteroscopy, is further expected to aid in the growth of the segment.

Moreover, the Crohn’s disease segment is projected to grow at a substantial rate during the analyzed period due to the increasing utilization of capsule endoscopes for the detection of Crohn’s disease. It is considered one of the most common types of Inflammatory Bowel Disease (IBD), and the rising prevalence of IBD, along with Crohn’s disease, is likely to augment market growth during the forecasted period. Canada has one of the highest incidence rates of IBD, including Crohn’s disease and ulcerative colitis. For instance, according to 2021 statistics provided by Crohn’s and Colitis Canada, around 260,000 people in the country were found to be living with IBD, which is a substantially high number. In addition, the IBD prevalence rate is anticipated to increase by 50% by the year 2030, with around 400,000 Canadians getting diagnosed with IBD, according to a study by Crohn’s and Colitis Canada in 2018.

Capsule Endoscopy Market Segmentation

• By Component
  • Sensors
  • Data Recorder & Work Stations
• By Product
  • Small Bowel Capsule
  • Esophageal Capsule
  • Colon Capsule
• By Application
  • Obscure Gastrointestinal Bleeding
  • Crohn’s Disease
  • Intestine Disease
  • Others
• By End-User
  • Hospital
  • Clinics
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Isreal
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Thailand
    • Taiwan
    • Others

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. CAPSULE ENDOSCOPY MARKET BY COMPONENT

5.1. Introduction

5.2. Sensors

5.3. Data Recorder & Work Stations

6. CAPSULE ENDOSCOPY MARKET BY PRODUCT

6.1. Introduction

6.2. Small Bowel Capsule

6.3. Esophageal Capsule

6.4. Colon Capsule

7. CAPSULE ENDOSCOPY MARKET BY APPLICATION

7.1. Introduction

7.2. Obscure Gastrointestinal Bleeding

7.3. Crohn’s Disease

7.4. Intestine Disease

7.5. Others

8. CAPSULE ENDOSCOPY MARKET BY END-USER

8.1. Introduction

8.2. Hospital

8.3. Clinics

8.4. Others

9. CAPSULE ENDOSCOPY MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. JInshan Science & Technology (Group) Co. Ltd

11.2. IntroMedic

11.3. Olympus Corporation

11.4. CapsoVision Inc.

11.5. Medtronic Plc.

11.6. RF Co., Ltd. 

11.7. Steris Corporation 

11.8. BioCam

11.9. AnX Robotics.

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

JInshan Science & Technology (Group) Co. Ltd

IntroMedic

Olympus Corporation

CapsoVision Inc.

Medtronic Plc.

RF Co., Ltd. 

Steris Corporation 

BioCam

AnX Robotics.